Résumé

Le diabète sucré (DS) touche 4% de la population générale tous âges confondus et 7% de la population de sujets âgés de plus de 65 ans. Il se définit par une glycémie à jeun sur sang veineux supérieure à 1,26 g/l à deux reprises ou par une glycémie à n’importe quel moment de la journée supérieure à 2 g/l. En pratique, on ne recourt plus au test d’hyperglycémie orale provoquée. La classification du diabète sucré a été révisée en 1997 et comprend plusieurs formes.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. 1.
    Larger E, Dubois-Laforgue D, Timsit J. [Type 1 diabetes mellitus]. Presse Med 1999; 28: 1895–1903.PubMedGoogle Scholar
  2. 2.
    Reffet S, Thivolet C. [Type 1 diabetes of the child and adult]. Rev Prat 2007; 57:71–78.PubMedGoogle Scholar
  3. 3.
    Grimaldi A. [Type 2 diabetes of the adult]. Rev Prat 2007; 57:531–536.PubMedGoogle Scholar
  4. 4.
    Romano G, Moretti G, Di Benedetto A et al. Skin lesions in diabètes mellitus: prevalence and clinical implications. Diab Res Clin Pract 1998; 39:101–106.CrossRefGoogle Scholar
  5. 5.
    Diris N, Colomb M, Leymarie F et al. [Non infectious skin conditions associated with diabetes mellitus: a prospective study of 308 cases]. Ann Dermatol Venereol 2003; 130:1009–1014.PubMedGoogle Scholar
  6. 6.
    Morgan AJ, Schwartz RA. Diabetic dermopathy: a subtle sign with grave implications. J Am Acad Dermatol 2008; 58:447–451.PubMedCrossRefGoogle Scholar
  7. 7.
    Shemer A, Bergman R, Linn S et al. Diabetic dermopathy and internal complications in diabetes mellitus. Int J Dermatol 1998; 37:113–115.PubMedCrossRefGoogle Scholar
  8. 8.
    Ngo BT, Hayes KD, DiMiao DJ et al. Manifestations of cutaneous diabetic microangiopathy. Am J Clin Dermatol 2005; 6:225–237.PubMedCrossRefGoogle Scholar
  9. 9.
    De Schepper S, Naaeyaert J-M. Acanthosis nigricans. EMC (Elsevier SAS, Paris), Dermatologie, 98-670-A-10, 2006.Google Scholar
  10. 10.
    Humbert Ph, Nguyen N’U. [Physiopathology of acanthosis nigricans]. Ann Dermatol Venereol 1998; 125:851–855.PubMedGoogle Scholar
  11. 11.
    Rosenbach A, Ram R. Treatment of Acanthosis nigricans of the axillae using a longpulsed (5-msec) alexandrite laser. Dermatol Surg 2004; 30:1158–1160.PubMedCrossRefGoogle Scholar
  12. 12.
    Peyrí J, Moreno A, Marcoval J. Necrobiosis lipoidica. Semin Cutan Med Surg 2007; 26:87–89.PubMedCrossRefGoogle Scholar
  13. 13.
    Vignon-Pennamen MD, Clerici T. [Palisading granuloma]. Ann Dermatol Venereol 1998; 125:615–619.PubMedGoogle Scholar
  14. 14.
    Huntley AC. Finger pebbles: a common finding in diabetes mellitus. J Am Acad Dermatol 1986; 14:612–617.PubMedCrossRefGoogle Scholar
  15. 15.
    Cabo HA. Thick skin syndrome in diabetes mellitus. J Eur Acad Dermatol Venereol 2000; 14: 143–144.PubMedCrossRefGoogle Scholar
  16. 16.
    Barde C, Masouyé I, Saurat JH, Le Gal FA. Sclerodema adultorum Buschke in a diabetic subject: intraveinous immnoglobulin therapy. Ann Dermatol Venereol 2009; 136:360–363.PubMedCrossRefGoogle Scholar
  17. 17.
    Basarab T, Munn SE, McGrath J, Russell Jones R. Bullosis diabeticorum. A case report and literature review. Clin Exp Dermatol 1995; 20:218–220.PubMedCrossRefGoogle Scholar
  18. 18.
    Kluger N, Guillot B. Dermatoses par élimination transépidermique (dermatoses perforantes). EMC (Elsevier Masson SAS, Paris), Dermatologie, 98-778-A-10, 2009.Google Scholar
  19. 19.
    Rajagopalan S. Serious infections in elderly patients with diabetes mellitus. Clin Infect Dis 2005; 40:990–996.PubMedCrossRefGoogle Scholar
  20. 20.
    Gupta AK, Humke S. The prevalence and management of onychomycosis in diabetic patients. Eur J Dermatol 2000; 10:379–384.PubMedGoogle Scholar
  21. 21.
    Tuazon CU. Skin and skin structure infections in the patient at risk: carrier state of Staphylococcus aureus. Am J Med 1984; 76:166–171.PubMedCrossRefGoogle Scholar
  22. 22.
    Benamor S, Senet P, Chosidow O. Manifestations cutanéomuqueuses du diabète. Encycl Méd Chir (Éditions scientifiques et médicales Elsevier SAS, Paris, tous droits réservés), Dermatologie, 98-866-A10, 2002, 6 p.Google Scholar
  23. 23.
    Nucci M. Emerging moulds: Fusarium, Scedosporiumand Zygomycetes in transplant recipients. Curr Opin Infect Dis 2003; 16:607–612.PubMedCrossRefGoogle Scholar
  24. 24.
    Martín-Moro JG, Calleja JM, García MB et al. Rhinoorbitocerebral mucormycosis: a case report and literature review. Med Oral Patol Oral Cir Bucal 2008; 13:E792–5PubMedGoogle Scholar
  25. 25.
    Serrao R, Zirwas M, English JC. Palmar erythema. Am J Clin Dermatol 2007; 8:347–356.PubMedCrossRefGoogle Scholar
  26. 26.
    Hoffman AG, Schram SE, Ercan-Fang NG, Warshaw EM. Type I allergy to insulin: case report and review of localized and systemic reactions to insulin. Dermatitis 2008; 19:52–58.PubMedGoogle Scholar
  27. 27.
    Richardson T, Kerr D. Skin-related complications of insulin therapy: epidemiology and emerging management strategies. Am J Clin Dermatol 2003; 4:661–667.PubMedCrossRefGoogle Scholar
  28. 28.
    Radermecker RP, Piérard GE, Scheen AJ. Lipodystrophy reactions to insulin: effects of continuous insulin infusion and new insulin analogs. Am J Clin Dermatol 2007; 8:21–28.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag France, Paris 2012

Authors and Affiliations

  • Didier Bessis

There are no affiliations available

Personalised recommendations